Baird Starts Myovant Sciences Ltd. (MYOV) at Outperform
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Citi Starts Myovant Sciences Ltd. (MYOV) at Buy
November 21, 2016 7:39 AM ESTCiti initiated coverage on Myovant Sciences Ltd. (NYSE: MYOV) with a Buy rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Myovant Sciences Ltd. click here. For more ratings news on Myovant Sciences Ltd. click here.
Shares of Myovant Sciences Ltd. closed at $11.25 yesterday.
... MoreCowen Starts Myovant Sciences Ltd. (MYOV) at Outperform
November 21, 2016 7:39 AM ESTCowen initiated coverage on Myovant Sciences Ltd. (NYSE: MYOV) with an Outperform rating.
For an analyst ratings summary and ratings history on Myovant Sciences Ltd. click here. For more ratings news on Myovant Sciences Ltd. click here.
Shares of Myovant Sciences Ltd. closed at $11.25 yesterday.
... MoreJMP Securities Starts Myovant Sciences Ltd. (MYOV) at Market Outperform
November 21, 2016 7:38 AM ESTJMP Securities initiated coverage on Myovant Sciences Ltd. (NYSE: MYOV) with a Market Outperform rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Myovant Sciences Ltd.... More
Barclays Starts Myovant Sciences Ltd. (MYOV) at Overweight
November 21, 2016 7:38 AM ESTBarclays initiated coverage on Myovant Sciences Ltd. (NYSE: MYOV) with an Overweight rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Myovant Sciences Ltd. click here. For more ratings news on Myovant Sciences Ltd. click here.
Shares of Myovant Sciences Ltd. closed at $11.25 yesterday.
... More